Summa Corp. cut its position in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 27.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,404 shares of the company’s stock after selling 3,643 shares during the quarter. Summa Corp.’s holdings in BlackRock Health Sciences Trust were worth $363,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Ameriflex Group Inc. bought a new stake in BlackRock Health Sciences Trust in the 4th quarter worth approximately $41,000. Comerica Bank raised its stake in shares of BlackRock Health Sciences Trust by 13.1% during the fourth quarter. Comerica Bank now owns 4,454 shares of the company’s stock worth $169,000 after acquiring an additional 517 shares in the last quarter. First Trust Advisors LP lifted its holdings in shares of BlackRock Health Sciences Trust by 6.1% in the 4th quarter. First Trust Advisors LP now owns 6,856 shares of the company’s stock worth $260,000 after acquiring an additional 393 shares during the last quarter. HBK Sorce Advisory LLC lifted its holdings in shares of BlackRock Health Sciences Trust by 14.8% in the 4th quarter. HBK Sorce Advisory LLC now owns 8,194 shares of the company’s stock worth $311,000 after acquiring an additional 1,057 shares during the last quarter. Finally, Yakira Capital Management Inc. purchased a new stake in shares of BlackRock Health Sciences Trust in the 4th quarter valued at $322,000.
BlackRock Health Sciences Trust Stock Down 1.4%
BME stock opened at $35.74 on Wednesday. The firm’s fifty day moving average is $36.21 and its 200 day moving average is $38.10. BlackRock Health Sciences Trust has a 52 week low of $34.18 and a 52 week high of $42.64.
BlackRock Health Sciences Trust Dividend Announcement
BlackRock Health Sciences Trust Company Profile
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Recommended Stories
- Five stocks we like better than BlackRock Health Sciences Trust
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- U.S. Steel Stock Burns the Bears With Surprise Upside Move
- How Can Investors Benefit From After-Hours Trading
- Lululemon, UNH, Enphase: Bad News, Good Opportunity?
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.